Corporate news
Liège, Belgium, December 2, 2024 – EXO Biologics and its CDMO subsidiary, ExoXpert, leading innovators in exosome-based therapeutics and…
ExoXpert Announces Agreement with Neucore Bio to Evaluate Advanced Exosome Loading Liege, Belgium, April 17, 2024 – ExoXpert®, a Contract…
Liege, Belgium, January 31, 2024 – EXO Biologics SA, a Belgian biotech company committed to developing biopharmaceuticals using exosomes to…
